News

The School of Chinese Medicine has achieved a historic milestone, with seventeen of its scholars named among the World’s Top 2% Most-Cited Scientists in 2026 by Stanford University, marking an all-time high for the School.

The honoured scholars span a diverse spectrum of disciplines, including Medicinal & Biomolecular Chemistry, Complementary & Alternative Medicine, Neurology & Neurosurgery, Biochemistry & Molecular Biology, and Clinical Medicine, demonstrating the profound and innovative integration of Chinese medicine with modern life sciences, as well as the School’s broad international impact across multiple research domains.

The School stands out particularly in the field of “Complementary & Alternative Medicine”, with Professor Lyu Aiping (Vice-President (Research and Development) and Dr. Kennedy Y.H. Wong Endowed Professor in Chinese Medicine) ranked 2^nd globally and Professor Bian Zhaoxiang (Associate Vice-President (Clinical Chinese Medicine) and Tsang Shiu Tim Endowed Professor in Chinese Medicine Clinical Studies) ranked 9th. Alongside senior scholars who anchor the list, several early-career scholars have also earned their places, bearing testament to the School’s enduring legacy and thriving research pipeline.

Professor Li Min, Dean of Chinese Medicine, congratulated the scholars and remarked, “The distinction that nearly half of our academic staff have been recognised among the world’s top 2% scientists not only affirms the School’s robust research excellence and highlights the growing international academic impact of Chinese medicine, but also demonstrates that our strategic roadmap for advancing Chinese medicine development and scientific innovation is yielding significant results.”

Looking ahead, SCM remains steadfastly committed to deepening transdisciplinary collaboration, nurturing future leaders in Chinese medicine research, and driving global health forward by transforming pioneering innovations into tangible benefits for society.